arrow
返回

许永 (Yong Xu)

Institute for Hepatology

44H指数
214论文数
6.8K被引数
收录论文 130
发表时间
Chemo-Enzymatic Synthesis of a Squalamine Intermediate by an Engineered Ketoreductase from Novosphingobium aromaticivorans芳香烃降解诺沃斯芬戈杆菌工程酮还原酶介导的鱼鲨胺中间体的化学生物酶合成
err2026-06-08
err0
PREAI
errZhe Zhang; Yan Zhang; Zhen Du; Xiaomin Zheng; Hongrui Xu; Yanxia Lin; Peng Kong; Hong Li; Jianchun Cao; Cheng Zhang; Shan Li; Yong Xu; Lei Zhang
err分享
err收藏
Discovery of a Highly Potent and Efficient BRD9 Degrader with Strong In Vivo Antitumor Activity发现一种高效且高活性的BRD9降解剂,具有强效的体内抗肿瘤活性
err2026-05-27
err0
PREAI
errXin Tang; Yumin Huang; Cheng Zhang; Yi Sun; Qingqing Hu; Guizhen Cheng; Jiankang Hu; Zhiming Chen; Xiaohan Zhang; Xiaoxi Zhuang; Adam V. Patterson; Jeff B. Smaill; Xishan Wu; Yan Zhang; Yong Xu; Hui Shen
err分享
err收藏
Discovery of ZX079 as a Dual PROTAC Degrader Targeting BRD4/CBP in Acute Myeloid LeukemiaZX079作为靶向急性髓系白血病中BRD4/CBP的双功能PROTAC降解剂的发现
err2026-02-17
err0
PREAI
errQiuping Xiang; Yanan Wang; Mengli Gu; Junchen Yao; Yanping Zhang; Cheng Zhang; Yong Zhang; Nan Xie; Shengyi Qian; Yan Lu; Hui Hua; Yujie Sun; Lin Wang; Manyu Guo; Qiaofeng Cao; Qin Zhu; Yao Chen; Qianyue Zhang; Xintian Zhang; Yuheng Wang; Chuhan Zhou; Shuhang Yuan; Mengdie Hu; Feng Li; Shuo Yang; Yong Xu; Dongsheng Zhu
err分享
err收藏
Discovery of Novel Indole Derivatives as LRH-1 Antagonists for the Treatment of Castration Resistant Prostate Cancer作为LRH-1拮抗剂的吲哚衍生物的发现,用于治疗去势抵抗性前列腺癌
err2026-02-16
err0
PREAI
errKaiyuan Ma; Weiqin Jin; Yan Zhang; Zhifang Lu; Xiaoxi Zhuang; Junhua Li; Xinyi Jing; Jun Wang; Liang Li; Yanan Zhou; Xin Li; Tingting Xu; Jinxin Xu; Jinming Ma; Junjie Deng; Xin Zhai; Bin Lin; Yong Xu; Hui Shen
err分享
err收藏
err分享
err收藏
Discovery of a Potent; Selective; and Multiple His435 Mutation-Sensitive Thyroid Hormone Receptor β Agonist发现一种强效、高选择性且受His435多重突变影响的甲状腺激素受体β激动剂
err2025-06-20
err0
PREAI
errQiu Li; Benqiang Yao; Shiting Zhao; Zhou Lu; Xishan Wu; Zhifang Lu; Tong Wu; Junhua Li; Xiaoshan Chen; Zhiming Chen; Cheng Zhang; Donghai Wu; Yan Zhang; Qiuping Xiang; Yong Li; Yong Xu
err分享
err收藏
Targeted disruption of PRC1.1 complex enhances bone remodeling靶向破坏PRC1.1复合物可增强骨重塑
err2025-05-08
err0
errOAAI
errXing, Liangyu; Xu, Jinxin; Gong, Meihan; Liu, Yunzhi; Li, Xuanyuan; Meng, Lingyu; Du, Ruyue; Zhou, Ying; Ouyang, Zhaoguang; Liu, Xu; Tao, Shaofei; Cao, Yuxin; Liu, Chunyi; Gao, Feng; Han, Ruohui; Shen, Hui; Dong, Yan; Xu, Yong; Li, Tao; Chen, He; Zhao, Yingying; Fan, Baoyou; Sui, Lei
err分享
err收藏
Identification of indoles as potential endogenous ligands of ERRγ and their modulation on drug binding吲哚作为ERRγ潜在内源性配体的鉴定及其对药物结合的调节
err2025-04-08
err0
PREAI
errShuai, YY; Zhang, HY; Chen, R; Wang, BL; Ding, P; Dong, Y; Sun, MZ; Wu, XS; Xu, Y; Zhang, Y; Liu, JS; Wang, N; Xu, TT
err分享
err收藏
Structural basis for the asymmetric binding of coactivator SRC1 to FXR-RXRα and allosteric communication within the complex
err2025-03-13
err0
errOAAI
errSheng, Yanan; Guo, Yaoting; Zhao, Beibei; Sun, Mingze; Dong, Yan; Yin, Yue; Wang, Yanwu; Peng, Chao; Xu, Yong; Wang, Na; Liu, Jinsong
err分享
err收藏
Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
err2024-11-27
err0
PREAI
errLi, Junhua; Hu, Qingqing; Zhu, Run; Dong, Ruibo; Shen, Hui; Hu, Jiankang; Zhang, Cheng; Zhang, Xiaohan; Xu, Tingting; Xiang, Qiuping; Zhang, Yan; Lin, Bin; Zhao, Linxiang; Wu, Xishan; Xu, Yong
err分享
err收藏
Discovery of CZL-046 with an (S)-3-Fluoropyrrolidin-2-one Scaffold as a p300 Bromodomain Inhibitor for the Treatment of Multiple Myeloma
err2024-10-02
err0
PREAI
errChen, Zonglong; Yang, Hong; Zhang, Yan; Lyu, Xiaodong; Shi, Qiongyu; Zhang, Cheng; Wang, Xingcan; Wang, Zekun; Zhang, Ying; Deng, Yue; Wang, Yujie; Huang, Yuting; Xu, Yong; Huang, Xun; Li, Yingxia
err分享
err收藏
Discovery of a Promising CBP/p300 Degrader XYD129 for the Treatment of Acute Myeloid Leukemia
err2024-06-03
err1
PREAI
errWu, Tianbang; Hu, Jiankang; Zhao, Xiaofan; Zhang, Cheng; Dong, Ruibo; Hu, Qingqing; Xu, Hongrui; Shen, Hui; Zhang, Xiaohan; Zhang, Yan; Lin, Bin; Wu, Xishan; Xiang, Qiuping; Xu, Yong
err分享
err收藏
Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong In Vivo Antitumor Activity
err2024-04-22
err3
PREAI
errHu, Jiankang; Xu, Hongrui; Wu, Tianbang; Zhang, Cheng; Shen, Hui; Dong, Ruibo; Hu, Qingqing; Xiang, Qiuping; Chai, Shuang; Luo, Guolong; Chen, Xiaoshan; Huang, Yumin; Zhao, Xiaofan; Peng, Chao; Wu, Xishan; Lin, Bin; Zhang, Yan; Xu, Yong
err分享
err收藏

研究方向

综合运用药物分子设计药物化学结构生物学恶性肿瘤等疾病新药物靶标发现与确证药物作用机制研究以及创新药物开发研究